- Home
- EJH vs QNCX Comparison
EJH vs QNCX Comparison
Compare EJH & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EJH | QNCX |
|---|---|---|
| Founded | 2018 | 2012 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4M | 6.9M |
| IPO Year | 2019 | 2019 |
Fundamental Metrics
Financial Performance| Metric | EJH | QNCX |
|---|---|---|
| Price | $1.80 | $1.25 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 832.9K | ★ 67.1M |
| Earning Date | 05-18-2026 | 04-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.07 | $0.08 |
| 52 Week High | $12.45 | $4.55 |
Technical Indicators
Market Signals| Indicator | EJH | QNCX |
|---|---|---|
| Relative Strength Index (RSI) | 68.21 | 79.65 |
| Support Level | $0.84 | $0.10 |
| Resistance Level | $2.80 | $1.99 |
| Average True Range (ATR) | 0.20 | 0.07 |
| MACD | 0.05 | 0.15 |
| Stochastic Oscillator | 63.67 | 84.48 |
Price Performance
Historical ComparisonAbout EJH E-Home Household Service Holdings Limited
E-Home Household Service Holdings Ltd is a household service company providing integrated household services through its website and WeChat platform across China. The company offers services including home appliance and housekeeping services. It operates its business mainly by receiving orders online and providing services offline. Its operations are organized into four reportable segments: appliance installation and maintenance services, housekeeping services, senior care services, and educational consulting services. The company generates the majority of its revenue from installation and maintenance.
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.